From interest to action: How health systems are implementing multi-cancer early detection
Only four cancers are routinely screened leaving most patients without early detection options. Multi-cancer early detection (MCED) is poised to change that.
This blood-based screening test is gaining national momentum, and health systems are taking note: 67% are planning to operationalize MCED, and nearly 1 in 4 have already launched full-scale programs.
This national survey of 100+ health system leaders shows how MCED is moving from possibility to practice.
Download the report to uncover:
This blood-based screening test is gaining national momentum, and health systems are taking note: 67% are planning to operationalize MCED, and nearly 1 in 4 have already launched full-scale programs.
This national survey of 100+ health system leaders shows how MCED is moving from possibility to practice.
Download the report to uncover:
- What’s driving MCED adoption at top systems
- Top barriers to scale and the tools leaders need to overcome them
- How MCED could reduce stage 4 cancer by 42% and cut mortality by 18%
Please fill out the form to download the whitepaper.